Filter
130
Text search:
European
Medicines
Agency
EMA
Featured
Recommendations
16
New Publications
30
Language
Document type
No document type
48
Guidelines
34
Studies & Reports
19
Fact sheets
18
Manuals
6
Situation Updates
2
Strategic & Response Plan
2
Training Material
1
Countries / Regions
Western and Central Europe
5
Germany
4
West and Central Africa
3
Brazil
2
East and Southern Africa
2
Africa
2
Guinea
1
Sierra Leone
1
Liberia
1
Congo, Democratic Republic of
1
Ethiopia
1
Uganda
1
Philippines
1
Nepal
1
Zambia
1
Kenya
1
Cambodia
1
Thailand
1
Indonesia
1
Bangladesh
1
Argentina
1
Ukraine
1
Ecuador
1
Latin America and the Carribbean
1
Paraguay
1
Venezuela
1
Eastern Europe
1
Denmark
1
Authors & Publishers
Publication Years
Category
Clinical Guidelines
25
Countries
19
Pharmacy & Technologies
6
Women & Child Health
5
Capacity Building
1
Public Health
1
Key Resources
1
Toolboxes
COVID-19
31
AMR
25
HIV
8
TB
8
Pharmacy
8
Ebola
7
Rapid Response
5
Refugee
3
Planetary Health
3
NTDs
3
Zika
2
Mental Health
2
Disability
1
Natural Hazards
1
Sepsis remains a leading cause of mortality and morbidity, especially during the first five days of life and in low and middle-income countries (LMIC) [1]. Hospital infection also remains a major cause of mortality in children despite progress encountered in the last decades.
Drugs, Diagnostics, Vaccines, Preventive Technologies, Research toward a cure, and immune-based and gene therapies in development
This document is part of the process for improving the quality of care in family planning. Medical eligibility criteria for contraceptive use (MEC), the first edition of which was published in 1996, prsents current World Health Organization (WHO) guidance on the safety of various contraceptive e-
m
...
HIV i-Base
July 2018
This document has been developed as a guide to allinstitutions producing health care waste in planning and implementation of interventions that will reduce mismanagement of hazardous waste in Zambia.The National Health-Care Waste Management Plan for 2015 to 2019 provides an overv
...
Interim rapid response guidance, 10 June 2022.
It includes considerations for certain populations such as patients with mild disease with considerations for community care, patients with moderate to severe disease, sexually active persons, pregnant or breastfeeding women, children and young persons
...
This document builds on the Background document prepared for the September 4-5, 2014 Consultation. It includes proposed elements to consider during the development of a framework to assist decision-making at global and national level.
The aim of the document is to assist Member States and releva
...
Minimizing risk of developing antibiotic resistance and aquatic ecotoxicity in the environment resulting from the manufacturing of human antibiotic.
The Standard, facilitated by BSI Standards Limited (BSI), provides clear guidance to manufacturers in the global antibiotic supply chain to ensure t
...
Humanitarian emergencies, regardless of type and cause, have a number of common risk factors for communicable diseases inextricably linked to excess risk of morbidity and mortality which can come from vaccine–preventable diseases (VPDs). The reduction of VPDs is a significant aim of public-health
...
29 September 2021
May 2018
HIV i-Base
ISSN 1475-2077 www.i-Base.info
Watch for out-of-date information
First questions
You and your doctor Resistance and adherence Treatment choices
PlosOne January 20, 2021
https://doi.org/10.1371/journal.pone.0241899
Antibiotic fixed dose combinations (FDCs) can have clinical advantages such as improving effectiveness and adherence to therapy. However, high use of potentially inappropriate FDCs has been reported, with implications for antim
...
Principles and Target Product Criteria. Roadmap January 12, 2015
Epidemiologisches Bulletin Nr.2 /2016, S.16
